Free Trial
NASDAQ:AIMD

Ainos (AIMD) Stock Price, News & Analysis

Ainos logo
$0.55 -0.01 (-0.91%)
As of 04/25/2025 04:00 PM Eastern

About Ainos Stock (NASDAQ:AIMD)

Key Stats

Today's Range
$0.54
$0.57
50-Day Range
$0.46
$0.66
52-Week Range
$0.40
$1.46
Volume
81,720 shs
Average Volume
565,846 shs
Market Capitalization
$8.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

Ainos Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
19th Percentile Overall Score

AIMD MarketRank™: 

Ainos scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Ainos.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ainos is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ainos is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Ainos has a P/B Ratio of 0.10. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Ainos' valuation and earnings.
  • Percentage of Shares Shorted

    9.15% of the float of Ainos has been sold short.
  • Short Interest Ratio / Days to Cover

    Ainos has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ainos has recently decreased by 23.63%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Ainos does not currently pay a dividend.

  • Dividend Growth

    Ainos does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.15% of the float of Ainos has been sold short.
  • Short Interest Ratio / Days to Cover

    Ainos has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ainos has recently decreased by 23.63%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Ainos has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Ainos this week, compared to 0 articles on an average week.
  • MarketBeat Follows

    2 people have added Ainos to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Ainos insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.39% of the stock of Ainos is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Ainos' insider trading history.
Receive AIMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ainos and its competitors with MarketBeat's FREE daily newsletter.

AIMD Stock News Headlines

Ainos (NASDAQ:AIMD) Shares Down 2% - What's Next?
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Elon Musk has done it again. He’s developed a powerful new AI model that’s already turning heads — and turning the industry upside down. Some say it could threaten Google’s search engine dominance. Others believe it could mark the beginning of the end for ChatGPT.
See More Headlines

AIMD Stock Analysis - Frequently Asked Questions

Ainos' stock was trading at $0.4560 on January 1st, 2025. Since then, AIMD shares have increased by 19.5% and is now trading at $0.5450.
View the best growth stocks for 2025 here
.

Ainos, Inc. (NASDAQ:AIMD) issued its quarterly earnings results on Friday, March, 7th. The company reported ($0.26) EPS for the quarter.

Ainos's stock reverse split on Thursday, December 14th 2023. The 1-5 reverse split was announced on Thursday, December 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Ainos (AIMD) raised $3 million in an IPO on Tuesday, August 9th 2022. The company issued 800,000 shares at $4.25 per share. Maxim Group served as the underwriter for the IPO and Brookline Capital Markets was co-manager.

Shares of AIMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ainos investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), e.l.f. Beauty (ELF), Disc Medicine (IRON), Jabil (JBL) and Adobe (ADBE).

Company Calendar

Last Earnings
3/07/2025
Today
4/25/2025
Next Earnings (Estimated)
5/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AIMD
Previous Symbol
NASDAQ:AIMD
Employees
40
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-13,770,000.00
Pretax Margin
-39,441.14%

Debt

Sales & Book Value

Annual Sales
$20,729.00
Price / Cash Flow
N/A
Book Value
$5.23 per share
Price / Book
0.10

Miscellaneous

Free Float
12,622,000
Market Cap
$8.41 million
Optionable
Not Optionable
Beta
1.83
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:AIMD) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners